CardioGraft® Pediatric Conduit

Download the files in the language of your choice
Instructions for Use
Product Specifications

CardioGraft® Pediatric Conduit

CardioGraft Pediatric Conduit is a cryopreserved human saphenous or femoral vein with competent valve for RV-PA reconstruction and cardiac shunts.

  • Competent Valve: Conduit valve identified and tested to confirm competency.
  • Human Tissue: Closely resembles autograft; compliant, flexible, easy to handle and suture.
  • Resistant to Infection: Ideal for infected sites and patients at risk of infection as vascular allografts are reported to have low incidence of infection.1-5
  • Convenient: Availability in various sizes to best fit the patient’s anatomy.
  • Reduced Thrombosis Potential: Alleviates the need for anticoagulation therapy.6,7
  • Effective: An effective option when a traditional pulmonary valve is not available.8-10
Clinical Application
  • Tetralogy of Fallot
  • Hypoplastic Left Heart Syndrome
  • Pulmonary Valve Stenosis/Atresia
  • Truncus Arteriosus
Description Sizing
PFV-C Femoral vein with competent valve. Cryopreserved Storage (-120°C and Below), 7 Year Shelf Life.  ≥ 6 cm/6 - 17 mm
PCV-C Saphenous vein with competent valve. Cryopreserved Storage (-120°C and Below), 7 Year Shelf Life. ≥ 6 cm/4 - 10 mm
References
  1. Bossi, M., Tozzi, M., Franchin, M., Ferraro, S., Rivolta, N., Ferrario, M., Guttadauro, C., Castelli, P., & Piffaretti, G. (2017). Cryopreserved human allografts for the reconstruction of aortic and peripheral prosthetic graft infection. Annals of Vascular Diseases, 10(4), 391-397. doi: 10.3400/avd.oa.17-00068
  2. Castier, Y., Francis, F., Cerceau, P., Besnard, M., Albertin, J., Fouilhe, L., Cerceau, O., Albaladejo, P. & Lesèche, G. (2005). Cryopreserved arterial allograft reconstruction for peripheral graft infection. Journal of vascular surgery, 41(1), 30-37. https://doi.org/10.1016/j.jvs.2004.09.025
  3. Harlander-Locke, M.P., Harmon, L.K., Lawrence, P.F., Oderich, G.S., McCready, R.A., Morasch, M.D., Feezor, R.J. & Vascular Low-Frequency Disease Consortium. (2014). The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States. Journal of vascular surgery, 59(3), 669-674. https://doi.org/10.1016/j.jvs.2013.09.009
  4. Madden, R. L., Lipkowitz, G. S., Browne, B. J., & Kurbanov, A. (2004). Experience with cryopreserved cadaveric femoral vein allografts used for hemodialysis access. Annals of vascular surgery, 18(4), 453-458. https://doi.org/10.1007/s10016-004-0055-0
  5. Mousavi, S. R., Moatamedi, M. R. K., & ME AKBARI, M. (2011). Comparing frozen saphenous vein with Gore-tex in vascular access for chronic hemodialysis. Hemodialysis International, 15(4), 559-562. https://doi.org/10.1111/j.1542-4758.2011.00578.x
  6. Hopkins et al. Cardiac Reconstructions with Allograft Tissues. Springer 2005.
  7. Pettersson, Coselli, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis. Journal of Thoracic and Cardiovascular Surgery, 2017; 153: 1241-1258.
  8. Bogats, et. al. Modified Blalock-Taussig Shunt Using Allograft Saphenous Vein: Six Years’ Experience, Ann Thorac Surg 1996;61:58-62.
  9. Schiller et al. Reconstruction of right ventricular outflow tract in neonates and infants using valved cryopreserved femoral vein homografts, The Journal of Thoracic and Cardiovascular Surgery, Volume 147, Issue 3, March 2014, Pages 874-879.
  10. Briceno-Medina, et. al (2018). Femoral vein homograft as Sano shunt results in improved pulmonary artery growth after Norwood operation. Cardiology in the Young, 28(1), 118-125.